NEJM
New England Journal of Medicine
NEJM
Clinician
NEJM
Evidence
NEJM
AI
NEJM
Catalyst
NEJM
Voices
Loading...
NEJM Research Summary
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
New England Journal of Medicine
Oct 28
1 min read
New England Journal of Medicine
October 28
1 min read
New England Journal of Medicine
October 28
1 min read
Related Content
Original Article
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
Journal Watch
A New, Targeted Treatment for Type 1 Narcolepsy
Topics
Neurology/Neurosurgery
Sleep
Clinical Medicine
Ambulatory Medicine